Sankei Chemical Co., Ltd. (FKSE:4995)

Sankei Chemical Balance Sheet

Financials in millions JPY. Fiscal year is December - November.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 31, 2026	Nov 30, 2025	Nov 30, 2024	Nov 30, 2023	Nov 30, 2022	Nov 30, 2021
Cash & Equivalents	1,953	1,969	1,903	1,644	2,084	2,161
Cash & Short-Term Investments	1,953	1,969	1,903	1,644	2,084	2,161
Cash Growth	29.42%	3.47%	15.75%	-21.11%	-3.56%	27.19%
Receivables	2,804	1,831	1,973	1,776	2,150	2,004
Inventory	1,361	1,449	1,438	1,645	1,613	1,544
Other Current Assets	38	111	61	111	57	67
Total Current Assets	6,156	5,360	5,375	5,176	5,904	5,776
Property, Plant & Equipment	1,231	1,213	1,106	1,131	961	733
Long-Term Investments	1,366	1,226	1,104	1,136	1,094	1,037
Other Intangible Assets	4	5	-	-	1	3
Long-Term Deferred Tax Assets	84	111	129	98	104	90
Other Long-Term Assets	1	1	1	2	2	1
Total Assets	8,842	7,916	7,715	7,543	8,066	7,640

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 31, 2026	Nov 30, 2025	Nov 30, 2024	Nov 30, 2023	Nov 30, 2022	Nov 30, 2021
Accounts Payable	1,306	983	877	780	1,165	1,197
Accrued Expenses	92	127	108	106	113	124
Current Portion of Long-Term Debt	623	595	695	777	770	730
Current Portion of Leases	22	22	21	19	20	20
Current Income Taxes Payable	131	21	51	6	50	96
Other Current Liabilities	503	680	506	429	607	553
Total Current Liabilities	2,677	2,428	2,258	2,117	2,725	2,720
Long-Term Debt	1,673	1,338	1,477	1,496	1,437	1,233
Long-Term Leases	42	43	45	33	29	33
Pension & Post-Retirement Benefits	447	446	458	441	436	420
Other Long-Term Liabilities	251	249	239	237	235	240
Total Liabilities	5,090	4,504	4,477	4,324	4,862	4,646

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 31, 2026	Nov 30, 2025	Nov 30, 2024	Nov 30, 2023	Nov 30, 2022	Nov 30, 2021
Common Stock	664	664	664	664	664	664
Additional Paid-In Capital	297	296	296	296	296	296
Retained Earnings	2,540	2,269	2,110	2,001	1,993	1,806
Treasury Stock	-142	-142	-141	-89	-68	-67
Comprehensive Income & Other	246	175	157	226	203	184
Total Common Equity	3,605	3,262	3,086	3,098	3,088	2,883
Minority Interest	147	150	152	121	116	111
Shareholders' Equity	3,752	3,412	3,238	3,219	3,204	2,994
Total Liabilities & Equity	8,842	7,916	7,715	7,543	8,066	7,640

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 31, 2026	Nov 30, 2025	Nov 30, 2024	Nov 30, 2023	Nov 30, 2022	Nov 30, 2021
Total Debt	2,360	1,998	2,238	2,325	2,256	2,016
Net Cash (Debt)	-407	-29	-335	-681	-172	145
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-454.17	-32.36	-369.12	-720.34	-179.49	151.29
Filing Date Shares Outstanding	0.9	0.9	0.9	0.94	0.96	0.96
Total Common Shares Outstanding	0.9	0.9	0.9	0.94	0.96	0.96
Working Capital	3,479	2,932	3,117	3,059	3,179	3,056
Book Value Per Share	4023.01	3639.97	3442.72	3292.10	3222.47	3008.39
Tangible Book Value	3,601	3,257	3,086	3,098	3,087	2,880
Tangible Book Value Per Share	4018.54	3634.39	3442.72	3292.10	3221.42	3005.26

Data Source: S&P Global Market Intelligence Last updated: May 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 12, 2026

Data Sources Report a data error